Edition:
United Kingdom

BioScrip Inc (BIOS.OQ)

BIOS.OQ on NASDAQ Stock Exchange Global Select Market

2.51USD
23 May 2018
Change (% chg)

$-0.02 (-0.79%)
Prev Close
$2.53
Open
$2.51
Day's High
$2.55
Day's Low
$2.50
Volume
20,114
Avg. Vol
183,537
52-wk High
$3.39
52-wk Low
$1.69

Chart for

About

BioScrip, Inc. is engaged in providing infusion solutions. The Company partners with physicians, hospital systems, skilled nursing facilities, healthcare payors and pharmaceutical manufacturers to provide patients access to post-acute care services. The Company operates through Infusion Services segment. The Company operates... (more)

Overall

Beta: 0.27
Market Cap(Mil.): $369.68
Shares Outstanding(Mil.): 127.48
Dividend: --
Yield (%): --

Financials

  BIOS.OQ Industry Sector
P/E (TTM): -- 28.41 32.75
EPS (TTM): -0.62 -- --
ROI: -13.44 6.42 14.38
ROE: -- 10.07 16.07

BRIEF-BioScrip Reports Qtrly Loss Per Share $0.12

* QTRLY LOSS PER SHARE $0.12 Source text for Eikon: Further company coverage:

10 May 2018

BRIEF-BioScrip Provides Update On Immaterial Financial Statement Corrections

* BIOSCRIP TIMELY FILES ANNUAL FORM 10-K, CONCLUDES ACCOUNTING REVIEW AND PROVIDES UPDATE ON IMMATERIAL FINANCIAL STATEMENT CORRECTIONS

26 Mar 2018

BRIEF-Bioscrip Inc Files For Non Timely 10-K - SEC Filing‍​

* BIOSCRIP INC FILES FOR NON TIMELY 10-K - SEC FILING‍​ Source text (http://bit.ly/2pbYT3N) Further company coverage: (Reuters.Brief@thomsonreuters.com)

15 Mar 2018

BRIEF-BioScrip Reports Q4 Preliminary Net Revenue Of $182.6 Mln

* BIOSCRIP REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS

08 Mar 2018

BRIEF-BioScrip Announces Additions To Senior Leadership Team

* BIOSCRIP - ‍ANNOUNCED APPOINTMENTS OF HARRIET BOOKER AS CHIEF OPERATING OFFICER, DANNY CLAYCOMB AS SENIOR VICE PRESIDENT, REVENUE CYCLE MANAGEMENT​ Source text for Eikon: Further company coverage:

28 Nov 2017

Earnings vs. Estimates